🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to analyze the safety and efficacy of CD3-CD20 bi...
Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2024-04-30
Trial ID
NCT06464185
Treatments Being Tested
A phase 1/2, open-label, safety and dosing study of autologous CART cells (...
Status
Recruiting
Location
Stanford University, Dept. of Dermatology
Start Date
2020-09-29
Trial ID
NCT04422912
Treatments Being Tested
This pilot study examines the safety and efficacy of anti-CD19 CAR T cells ...
Status
Not Yet Recruiting
Location
Nationwide Children's Hospital
Start Date
2025-10
Trial ID
NCT05779930
Treatments Being Tested
The goal of this clinical trial is to characterize to understand the effect...
Status
Recruiting
Location
Stanford University
Start Date
2024-08-02
Trial ID
NCT06298019
Treatments Being Tested
The goal of this clinical research study is to learn if an infusion of whit...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-12-07
Trial ID
NCT01362452
Treatments Being Tested
This study is a prospective, single center phase II clinical trial in which...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2021-01-21
Trial ID
NCT04558736
The goal of this Phase I clinical trial is to evaluate the safety and toler...
Status
Recruiting
Location
Vinmec Research Institute of Stem Cell and Gene Technology
Start Date
2026-03-01
Trial ID
NCT07432334
Treatments Being Tested
The previous research suggests that the low expression of NOXA protein may ...
Status
Unknown
Location
Beijing Tongren Hospital, Capital Medical University
Start Date
2022-05-25
Trial ID
NCT05370547
Treatments Being Tested
This is a Phase 1b/2, multicenter, open-label, study of JNJ-90014496, an au...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2022-08-12
Trial ID
NCT05421663
Treatments Being Tested
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy...
Status
Recruiting
Location
University of California Irvine
Start Date
2024-02-16
Trial ID
NCT06121297